NORMAL
PHARMA 7081
RM2.42
52 Weeks Range : 0.91 - 2.88
4.0/10
(Expert Score)
Stock is rated as #12 in category BM Health Care
Hold Recommendation. Current price is fairly valued.
PROS:
- Profitable business
- High Dividend Yield
- Very High Trading Value
CONS:
- Very Low Price-to-Tangible
- High Debt Company
- Very High Gearing
klse: Pharmaniaga Bhd
Corporate Information
Board : Main
Shariah : Shariah Compliant
Sector : Ringgit Consumer Healthcare
Address: No. 7, Lorong Keluli 1B, Kawasan Perindustrian Bukit Raja Selatan, Seksyen 7, Shah Alam, 40000, Selangor
Contact: +603-33429999
Website: https://www.pharmaniaga.com/
Corporate Background
Pharmaniaga Berhad is an investment holding company. The Company, through its subsidiaries, manufactures, markets, and distributes pharmaceutical and medical products to government hospitals and private institutions. Pharmaniaga also provides web portal services for online trading of health care products.
Forecast: PHARMA 7081
| Number of Share | 261, 229, 732 |
|---|---|
| Market Capital (RM) | 632, 175, 951 |
| Forecasted Profit or Loss (RM) | 45, 673, 446 |
| Estimated Future EPS (sen) | 17.484 |
| Perspective P/E ratio | 13.841 |
| Estimated Dividend Yield (%) | 3.771 |
| Adjusted NTA (RM) | 0.803 |
Result
Quarter Report History
| Date | Revenue,k | PBT,k | Net Profit,k |
|---|---|---|---|
| 19/05/20 | 819,921 | 30,880 | 22,399 |
| 20/02/20 | 715,683 | -238,474 | -178,598 |
| 20/11/19 | 716,849 | 3,885 | 481 |
| 23/08/19 | 601,890 | 12,481 | 9,281 |
| 16/05/19 | 786,108 | 30,243 | 19,617 |
| 21/02/19 | 596,644 | 11,940 | 4,437 |
| 19/11/18 | 587,660 | 17,603 | 15,051 |
| 17/08/18 | 582,729 | 11,970 | 5,394 |
| 16/05/18 | 617,923 | 28,707 | 17,586 |
| 27/02/18 | 613,196 | 19,866 | 21,700 |
| 15/11/17 | 574,503 | 15,271 | 3,580 |
| 16/08/17 | 517,967 | 10,150 | 9,520 |
Fundamental
Fundamental Analysis
| Last 4 Quarter Revenue (RM’000) | 2,854,343 |
|---|---|
| Last 4 Quarter Net Profit (RM’000) | -146,680 |
| Last 4 Quarter EPS (sen) | -56.14 |
| Last 4 Quarter PER | – |
| Last 4 Quarter Dividend (sen) | 8.50 |
| Last 4 Quarter Dividend Yield (%) | 3.51 |
| Net Tangible Assets (RM) | 1.29 |
| Goodwill (RM) | 200,340 |
| Cash (RM’000) | 29,590 |
| Debt (RM’000) | 568,880 |
| Total Debt (RM’000) | 1,230,000 |
| Net Assets (RM’000) | 337,850 |
| Current Ratio | 0.78 |
| Quick Ratio | 0.26 |
| Cash Ratio | 0.02 |
Technical
Technical Analysis
| MACD (26 vs 12) | 0.172 |
|---|---|
| Exponential Moving Average 5 | 2.445 |
| Exponential Moving Average 20 | 2.333 |
| Exponential Moving Average 90 | 1.97 |
| Relative Strength Index 14 | 0.46 |
| Stochastic %D 3 | 0.48 |
| Stochastic %K 14 | 0.18 |
6 reviews for PHARMA 7081
Show all
Most Helpful
Highest Rating
Lowest Rating
Investing Malaysia –
PHARMA is estimated to have a profit consensus of 44.98 millions, with an adjusted market capitalization of 478.05 millions
Investing Malaysia –
Stock code of 7081 in Bursa Malaysia declared adjusted 6.42% dividend yield in past few years
Investing Malaysia –
Pharmaniaga Bhd gets a score of 10.15 in our stability test after the balance sheet, money statement study
Investing Malaysia –
PHARMA gets a score of 10.92 in our equity and assets quality test based on current share price of RM1.9
Investing Malaysia –
Average investing volume for Pharmaniaga Bhd in the past three months in stock market was 296.7k lots
INVESTING MALAYSIA –
PHARMA 21 JAN 20 – Pharmaniaga Bhd says its managing director (MD) Datuk Farshila Emran will leave the company when her contract expires at the end of March this year, confirming a report by theedgemarkets.com earlier today.